BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: MicroRNA-301b (miR-301b); interleukin-4 (IL-4) (BSF1); transforming growth factor β 1 (TGFβ1)

September 1, 2016 7:00 AM UTC

Cell culture and mouse studies suggest that inhibiting the expression of miR-301b could help treat Pseudomonas, Streptococcus and other Gram-negative bacterial infections. In lipopolysaccharide (LPS)-...